English » Research Activity » Funding

Funding

  1. CANCER blood-scan: Liquid biopsy: Development, validation and clinical evaluation of novel molecular diagnostic assays for tumor biomarkers in peripheral blood. GSRT, ESPA, Code: Τ1ΕΔΚ-02935, 2018-2021
  2. Honor Scholarships by SNF: "Liquid biopsy-Molecular diagnosis of cancer" -Funder: Stavros Niarchos Foundation within the framework of a grant to the National and Kapodistrian University of Athens [no.16785], Budget: 180.000 €, Project duration:  22/01/2018 - 21/01/2021
  3. TRANSCAN-2: "Early detection of prostate cancer by liquid biopsies" (https://www.transcanfp7.eu/index.php/abstract/prolipsy.html)
    Partner 1: (Coordinator): Prof. Klaus PANTEL (Germany) University Medical Centre Hamburg Eppendorf, Hamburg
    Partner 2: Prof. Desiree BONCI (Italy) Istituto Superiore di Sanità, Rome
    Partner 3: Dr. Catherine Alix-Panabières (France) University Medical Centre of Montpellier, Montpellier
    Partner 4:  Prof. E.S. Lianidou ACTC lab, Dept of Chemistry, (Greece) Univ of Athens
    Partner 5: Prof. Maciej ZABEL (Poland), Poznan University of Medical Sciences, Poznan
  4. CANCER-ID: Cancer treatment and monitoring through identification of circulating tumor cells and tumor related nucleic acids in blood (http://www.cancer-id.eu/), (https://www.cancer-id.eu/partners/academic-partners/university-of-athens/), 2016-2019
  5. TRANSCAN:"CTC-SCAN: Circulating Tumour Cells as Biomarker for Minimal Residual Disease in Prostate Cancer"
    Partner 1: University Medical Center Hamburg-Eppendorf, Germany - the Coordinator -, PI: Prof. K. Pantel
    Partner 2: University Medical Centre of Montpellier Saint-Eloi Hospital, France, PI: Dr. C. Alix-Panabières
    Partner 3: ACTC lab, Dept of Chemistry, Univ of Athens, Greece, PI: Prof. E.S. Lianidou
    Partner 4: Medical University of Graz, Austria
    Partner 5: Poznan University of Medical Sciences, Poland
  6. Greek Germany Cooperation: "Liquid biopsy: In vivo capturing and molecular characterization of circulating tumor cells as a novel tool for improving tertiary prevention in breast cancer" Partners:
    1) Greece: ACTC lab, Dept of Chemistry, Univ of Athens, PI: Prof. E.S. Lianidou
    2) Greece: Lab of Tumor Biology, Medical School, Univ of Crete, PI: Prof V. Georgoulias
    3) Germany: University Medical Center Hamburg-Eppendorf, Germany, PI: Prof. K. Pantel
    4) Germany: GILUPI GmbH c/o Innovationszentrum Golm, R&D Company, Potsdam, Germany, PI: K. Lucke
  7. "Study and clinical evaluation of novel molecular biomarkers for breast cancer". Grant: Herakleitos, Duration: 3 years Amount: 45.000 €, Funding agency: Greek Ministry of Education
  8. OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distal Metastasis & Development of Liquid Biopsy Methods. Grant: Cooperation, Duration: 5 years, Amount: 180.000 € (our lab), Funding agency: General Secretariat of Research and Technology of Greece
  9. "Development and clinical evaluation of DNA methylation assays in paraffin-embedded breast carcinomas and in cell-free circulating DNA in plasma of patients with early stage breast cancer". Grant: KESY oncology, Duration: 2 years, Amount: 12.000 €, Funding agency: Greek Ministry of Health
  10. "Molecular Diagnosis of micrometastatic disease in breast cancer by DNA microarrays". Grant: PENED 2003, Duration: 3 years, Amount: 150.000 €, Funding agency: General Secretariat of Research and Technology of Greece